Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Crinetics Pharmaceuticals (CRNX) Shares Outstanding: 2016-2024

Historic Shares Outstanding for Crinetics Pharmaceuticals (CRNX) over the last 9 years, with Dec 2024 value amounting to $92.9 million.

  • Crinetics Pharmaceuticals' Shares Outstanding rose 16.96% to $94.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $94.5 million, marking a year-over-year increase of 16.96%. This contributed to the annual value of $92.9 million for FY2024, which is 36.31% up from last year.
  • As of FY2024, Crinetics Pharmaceuticals' Shares Outstanding stood at $92.9 million, which was up 36.31% from $68.2 million recorded in FY2023.
  • In the past 5 years, Crinetics Pharmaceuticals' Shares Outstanding registered a high of $92.9 million during FY2024, and its lowest value of $33.0 million during FY2020.
  • Moreover, its 3-year median value for Shares Outstanding was $68.2 million (2023), whereas its average is $71.7 million.
  • Data for Crinetics Pharmaceuticals' Shares Outstanding shows a peak YoY spiked of 44.23% (in 2021) over the last 5 years.
  • Over the past 5 years, Crinetics Pharmaceuticals' Shares Outstanding (Yearly) stood at $33.0 million in 2020, then spiked by 44.23% to $47.6 million in 2021, then climbed by 13.19% to $53.9 million in 2022, then grew by 26.54% to $68.2 million in 2023, then soared by 36.31% to $92.9 million in 2024.